Company · CIK 0000034956 · SIC 2834 — Pharmaceutical Preparations · Nasdaq
TENAX THERAPEUTICS, INC. · TENX
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 16, 2026 PForm 4 → | Sep 17, 9:30 pm EDT | Declan DooganDirector | 53,000 | $1.92 | $101,760 | 55,274 | +2,331% | |
| Sep 11, 2026 PForm 4 → | Sep 15, 9:38 pm EDT | Christopher Thomas GiordanoCEO, Director | 10,850 | $1.85 | $20,087 | 22,174 | +95.8% | |
| Sep 11, 2026 PForm 4 → | Sep 15, 9:30 pm EDT | Thomas R Staab IIChief Financial Officer | 5,675 | $1.94 | $10,981 | 15,675 | +56.8% | |
| Sep 3, 2026 PForm 4 → | Sep 8, 5:16 pm EDT | ADAR1 Capital Management, LLC +110% Owner | 900,000 | $1.78 | $1,604,160 | 6,524,151 | +16.0% | |
| Aug 31, 2026 PForm 4 → | Sep 2, 5:52 pm EDT | ADAR1 Capital Management, LLC +110% Owner | 770,333 | $1.79 | $1,381,750 | 5,624,151 | +15.9% | |
| Aug 20, 2026 PForm 4 → | Aug 24, 6:12 pm EDT | ADAR1 Capital Management, LLC +110% Owner | 1,025,867 | $1.77 | $1,814,147 | 4,853,818 | +26.8% | |
| Jul 13, 2026 MForm 4 → | Jul 14, 7:29 pm EDT | Christopher Thomas GiordanoCEO, Director | 8,719 | $5.88 | $51,267 | 11,324 | — |
Reported at this company — derivatives (options, RSUs, warrants)
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 13, 2026 MForm 4 → | Jul 14, 7:29 pm EDT | Christopher Thomas GiordanoCEO, Director | 8,719 | — | — | 1,241,500 | — |